Healthcare Intelligence Network
Accountable Care Organizations
Best Sellers
Behavioral Healthcare
Benchmarking
Bundled Payment
Care Coordination
Care Transitions
Case Management
Chronic Care Management
Coaching
Coming Soon
Community Health
Compliance
Consumer-Driven
Cultural Diversity
Data Analytics
Diabetes Management
Disease Management
Dual Eligibles
e-Books
eHealthcare
Emergency Medicine
Health Literacy
Health Risk Assessments
Health Risk Stratification
Healthcare Reform
Healthcare Trends
HIN Benchmark Reports
HIN Case Studies
HIPAA
Home Health
Home Visits
Hospice
Hospital
Hospital Readmissions
Hospitalist
ICD-10
Infection Control
Infographics
Information Technology
Long-Term Care
MACRA
Managed Care
Medicaid
Medical Home
Medical Neighborhood
Medical Practice
Medical Records
Medicare
Medication Adherence
Nurse Management
Palliative Care
Patient Engagement
Patient Experience
Patient Registry
Pay for Performance
Physician Practice Transformation
Physician Organizations
Physician Quality Reporting Initiative
Population Health Management
Post-Acute Care
Predictive Modeling
Pre-Publication
Quality Improvement
Reimbursement
Remote Patient Monitoring
Revenue Cycle Management
Safety
Social Health Determinants
Telehealth
Training DVDs
Transparency
Value-Based Reimbursement
Webinars
Wellness
What's New
Subscribe to the Free
'Healthcare Business Weekly Update' e-Newsletter and receive the latest trends, news and analysis in healthcare.
Email:

Click here to view this week's issue
Home > Behavioral Healthcare
Attention Deficit Hyperactivity Disorder
Attention Deficit Hyperactivity Disorder
Attention Deficit Hyperactivity Disorder
Be the first to review this item
Price
Your Price:
$133.95
Quantity
Add to Wish List
Description

One in twenty children has ADHD. Substantial functional impairment accompanies the disorder—including elevated risk for serious accidents, problems in peer and family functioning, and below-average academic achievement.

This critically acclaimed reference surveys research in epidemiology, neuro-psychotherapy, neurobiology, psychopharmacology and psychotherapy, providing an authoritative review of the state of the science on ADHD diagnosis, causes, treatment and outcomes:

  • Biological bases and cognitive correlates of ADHD
  • Controversies regarding over- or under-diagnosis of ADHD
  • Effective treatments
  • Risks and rewards of treatment with stimulant medication
  • Use of non-stimulant medications and alternative treatments
  • Recognizing and treating co-occurring aggressive disorders and learning disabilities
  • Risk of substance abuse in the ADHD population
  • Adult outcomes for ADHD children
  • The impact of ADHD on individuals, families and society
  • Educating children with ADHD
  • Overcoming barriers to appropriate identification, evaluation and intervention
  • Directions for future research

“Comes at a time when there is an explosion of new information on the diagnosis, neurobiology and treatment of ADHD. With chapters by a virtual ‘who’s who’ of the field, presents the best scientific data about this disorder, illuminating the controversies and pointing out future needs. A major contribution!” —Judith L. Rapoport, M.D., Chief, Child Psychiatry Branch, National Institute of Mental Health “Unsurpassed in its scope, scholarship, and social relevance.” —Alan E. Kazdin, Ph.D., Professor and Director, Child Study Center, Yale University School of Medicine

Summary table of contents

PART 1: IS ADHD A REAL DISORDER?

Chapter 1: Validity of the Diagnosis and Dimensions of Attention Deficit Hyperactivity Disorder

Chapter 2: The Diagnostic Classification, Epidemiology, and Cross-Cultural Validity of ADHD

Chapter 3: Is ADHD a Valid Disorder?

Chapter 4: ADHD—Long-Term Course, Adult Outcome, and Comorbid Disorders

Chapter 5: Is ADHD and Impairing Condition in Childhood and Adolescence?

Chapter 6: The Impact of Attention Deficit Hyperactivity Disorder on Social and Vocational Functioning in Adults

PART 2: WHAT CAUSES ADHD?

Chapter 7: Biological Bases of ADHD—Neuroanatomy, Genetics, and Pathophysiology

Chapter 8: Cognitive Correlates of ADHD

PART 3: ARE ADHD TREATMENTS SAFE AND EFFECTIVE?

Chapter 9: Stimulant Medication Treatment of Children With Attention Deficit Hyperactivity Disorder

Chapter 10: Public Health and Toxicological Issues Concerning Stimulant Treatment for ADHD

Chapter 11: Nonstimulant Treatments for ADHD

Chapter 12: Psychosocial Interventions for ADHD

Chapter 13: Treatment Alternatives for Attention Deficit Hyperactivity Disorder

Chapter 14: Behavioral and Medication Treatments for ADHD—Comparisons and

Chapter 15: Matching Patients to Treatments

PART 4: DOES STIMULANT USE FOR ADHD LEAD TO SUBSTANCE ABUSE?

Chapter 16: Alcohol, Stimulants, Nicotine, and Other Drugs in ADHD

Chapter 17: Medicated vs. Unmedicated ADHD Children—Adult Involvement With Legal and Illegal Drugs

Chapter 18: Stimulant Treatment as a Risk Factor for Nicotine Use and Substance Abuse

Chapter 19: Attention Deficit Hyperactivity Disorder and Substance Use Disorders—The Nature of the Relationship, Subtypes at Risk, and Treatment Issues

Chapter 20: Diversion, Trafficking, and Abuse of Methylphenidate

Chapter 21: Availability of Stimulant Medications—Nature and Extent of Abuse and Associated Harm

Chapter 22: Treatment Services for Children With ADHD—A National Perspective

PART 5: EXISTING PRACTICES AND POLICIES REGARDING ASSESSMENT AND TREATMENT OF ADHD

Chapter 23: Current Assessment and Treatment Practices in ADHD

Chapter 24: Impact of ADHD on School Systems

Chapter 25: The Impact of Attention Deficit Hyperactivity Disorder on the Juvenile Justice System

Chapter 26: Educational Policy—Educating Children With Attention Deficit Hyperactivity Disorder

Chapter 27: Use of Services and Costs for Youth With ADHD and Related Conditions

Afterword: ADHD, Past, Present, and Future

Appendix: National Institutes of Health Consensus Statement

Publication Date: 2002
Number of Pages: 684
Three Pillars of Health Coaching: Patient Activation, Motivational Interviewing and Positive Psychology
Care Coordination of Highest-Risk Patients: Business Case for Managing Complex Populations
2019 Healthcare Benchmarks: Patient Engagement

Copyright Healthcare Intelligence Network. All Rights Reserved. eCommerce Software by 3dcart.